Cardioprotection against Heart Failure by Shenfu Injection via TGF-β/Smads Signaling Pathway

Figure 2

Representative echocardiographic images (M-mode) in different groups. Notes. (a) Sham group, (b) HF group, (c) Valsartan + HF group, (d) SFI 1.5 mL/kg + HF group, and (e) SFI 0.75 mL/kg + HF group. HF, heart failure; SFI, Shenfu injection.

(a)

(b)

(c)

(d)

(e)